Retatrutide Research Update: Why Triple-Agonist Peptides Are Getting Attention

A research-focused update on retatrutide, exploring why triple-agonist peptides are gaining attention in metabolic studies and how GLP-1, GIP and glucagon receptor pathways are being investigated.